According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 256,900,000. At the end of 2025 the company had 256,900,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 0.25 B | -0.23% |
2024 | 0.25 B | -0.08% |
2023 | 0.25 B | 0.31% |
2022 | 0.25 B | 0.9% |
2021 | 0.25 B | -2.09% |
2020 | 0.26 B | 0.79% |
2019 | 0.25 B | 1.23% |
2018 | 0.25 B | 1.32% |
2017 | 0.25 B | 2.49% |
2016 | 0.24 B | 1.02% |
2015 | 0.24 B | 1.98% |
2014 | 0.23 B | 3.03% |
2013 | 0.23 B | 7.76% |
2012 | 0.21 B | 4.18% |
2011 | 0.20 B | 2.55% |
2010 | 0.20 B | 12.39% |
2009 | 0.17 B | 27.57% |
2008 | 0.14 B | 7.77% |
2007 | 0.13 B | 15.25% |
2006 | 0.11 B | 19.25% |
2005 | 94.59 M | 20.13% |
2004 | 78.74 M | 2.17% |
2003 | 77.06 M | 1.43% |
2002 | 75.97 M | 1.74% |
2001 | 74.68 M | 38.7% |
2000 | 53.84 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Gilead Sciences GILD | 1,246,000,000 | 385.01% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 1,768,000,000 | 588.21% | ๐บ๐ธ USA |
![]() Merck MRK | 2,516,394,128 | 879.52% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 2,031,000,000 | 690.58% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | 2,405,625,000 | 836.41% | ๐บ๐ธ USA |
![]() Enanta Pharmaceuticals
ENTA | 21,355,000 | -91.69% | ๐บ๐ธ USA |